Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial

التفاصيل البيبلوغرافية
العنوان:	Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial
المؤلفون:	O'Donnell, Elizabeth ^*, Mo, Clifton, Yee, Andrew J, Nadeem, Omar, Laubach, Jacob, Rosenblatt, Jacalyn, Munshi, Nikhil, Midha, Shonali, Cirstea, Diana, Chrysafi, Pavlina, Horick, Nora, Richardson, Paul G, Raje, Noopur
المصدر:	In The Lancet Haematology June 2024 11(6):e415-e424
قاعدة البيانات:	ScienceDirect

كن أول من يترك تعليقا!